A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection

NCT04991688 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Organizational difficulties

Conditions

Low Anterior Resection Syndrome (LARS>20)
Refractory Medical Treatment After Rectal Resection

Interventions

DRUG: BOTOX-A

Sponsor

University Hospital, Bordeaux